0001654954-22-013281.txt : 20221003 0001654954-22-013281.hdr.sgml : 20221003 20221003195727 ACCESSION NUMBER: 0001654954-22-013281 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221003 DATE AS OF CHANGE: 20221003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STARR CHRISTOPHER M CENTRAL INDEX KEY: 0001235470 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 221289274 MAIL ADDRESS: STREET 1: C/O MONOPAR THERAPEUTICS INC STREET 2: 1000 SKOKIE BLVD., SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320463781 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 BUSINESS PHONE: 8473880349 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2022-09-30 0001645469 Monopar Therapeutics MNPR 0001235470 STARR CHRISTOPHER M 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 true false false Common Stock 2022-09-30 4 M false 2859 A 12871 D Common Stock 49400 I See Footnote Restricted Stock Units 2022-09-30 4 M false 2859 0 D Common Stock 2859 2859 D Represents shares acquired on vesting and settlement of restricted stock units. 49,400 shares of common stock held by the Christopher M. Starr and Sheri L. Starr Revocable Trust over which Dr. Starr serves as Trustee. On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. /s/ Kim R. Tsuchimoto, Attorney-in-fact 2022-10-03